OncoGenex Pharmaceuticals

Type: Company
Name: OncoGenex Pharmaceuticals
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

OncoGenex Pharmaceutical Makes a Move: Down 1.6%

One of today's stocks on the move is OncoGenex Pharmaceutical (NASDAQ:OGXI), down 1.6% to $9.84. The S&P is trading higher by 0.3% to 1,849 and the Dow is trading 0.4% higher to 16,329. ... [Published Individual.com - Apr 16 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 2 reports

OncoGenex Pharmaceutical Shares Down 15.3% Since SmarTrend's Sell Call (OGXI)

Written on Fri, 04/11/2014 - 10:54amBy James QuinnSmarTrend identified a Downtrend for OncoGenex Pharmaceutical ( NASDAQ:OGXI ) on March 27th, 2014 at $11.44. In approximately 2 weeks, OncoGenex Pharmaceutical has returned 15.27% as of today's recent ... [Published Comtex SmarTrend - Apr 11 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

OncoGenex Pharmaceuticals Rating Increased to Overweight at EVA Dimensions (OGXI)

OncoGenex Pharmaceuticals (NASDAQ:OGXI)Separately, analysts at CRT Capital initiated coverage on shares of OncoGenex Pharmaceuticals in a research note on Thursday, February 27th. They set a "buy" rating and a $20.00 price target on the stock. Six equities ... [Published American Banking News - Apr 09 2014]
First reported Apr 07 2014 - Updated Apr 07 2014 - 1 reports

Shares of OncoGenex Pharmaceutical Are Down on Strong Volume (OGXI)

The price of OncoGenex Pharmaceutical shares has slipped to $9.97 (a 2.1% change) on heavy trading volume. Today's volume of 451,000 shares tops the average 30-day volume of 287,000 shares. Unusually high volume can signify a potential turning point ... [Published Individual.com - Apr 07 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

OncoGenex Pharmaceutical Shares Sinking Lower, Down 4.8%

Written on Fri, 04/04/2014 - 12:26pmBy Shiri GuptaOncoGenex Pharmaceutical ( NASDAQ:OGXI ) is a company whose shares are active, trading 4.8% lower to $10.28. The S&P is trading lower by 0.4% to 1,880 and the Dow is trading 0.2% lower to 16,534.OncoGenex ... [Published Comtex SmarTrend - Apr 04 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Short Interest in OncoGenex Pharmaceuticals Rises By 36.1% (OGXI)

Tweet[embedded content]OncoGenex Pharmaceuticals (NASDAQ:OGXI) was the target of a significant growth in short interest during the month of January. As of March 14th, there was short interest totalling 930,484 shares, a growth of 36.1% from the February ... [Published Zolmax News - Apr 03 2014]
First reported Mar 23 2014 - Updated Mar 23 2014 - 1 reports

ONCOGENEX PHARMACEUTICALS : Reports Financial Results for Fourth Quarter and Year End 2013

OncoGenex Pharmaceuticals, Inc. announced that it provided a summary of clinical developments and anticipated near-term milestones and announced fourth quarter and year end 2013 financial results.In a release on March 11 , the company noted earnings ... [Published 4 Traders - Mar 23 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

OncoGenex Pharmaceutical Shares Up 65.9% Since SmarTrend's Buy Recommendation (OGXI)

SmarTrend identified an Uptrend for OncoGenex Pharmaceutical (NASDAQ:OGXI) on November 21st, 2013 at $7.97. In approximately 4 months, OncoGenex Pharmaceutical has returned 65.87% as of today's recent price of $13.22. ... [Published Individual.com - Mar 21 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 2 reports

OncoGenex Pharmaceuticals CMO Sells $15,313 in Stock (OGXI)

OncoGenex Pharmaceuticals (NASDAQ:OGXI) CMO Cindy Jacobs sold 1,250 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $12.25, for a total value of $15,312.50. Following the transaction, ... [Published American Banking News - Mar 19 2014]
First reported Mar 11 2014 - Updated Mar 12 2014 - 5 reports

Narrower-than-Expected Loss at OncoGenex - Analyst Blog

Fourth quarter 2013 revenues were $8.6 million, down 12% from the year-ago quarter. Revenues were below the Zacks Consensus Estimate of $10 million. OncoGenex's revenues comprised solely of collaboration revenues.Collaboration revenues were earned from ... [Published Nasdaq - Mar 12 2014]
First reported Mar 11 2014 - Updated Mar 12 2014 - 6 reports

Narrower-than-Expected Loss at OncoGenex

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.OncoGenex Pharmaceuticals, Inc.  ( OGXI - Snapshot ... [Published Zacks.com - Mar 12 2014]
First reported Feb 25 2014 - Updated Feb 25 2014 - 3 reports

OncoGenex to Report Financial Results for Fourth Quarter and YearEnded 2013 on March 11 2014

BOTHELL, Wash. and VANCOUVER, British Columbia , Feb. 25, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's fourth quarter and year-ended 2013 financial results will be released on Tuesday, March 11, ... [Published BioPortfolio - Feb 25 2014]

Quotes

NEXT ARTICLE More From BioPortfolio on "OncoGenex to Report Financial Results for Fourth Quarter and Year-Ended 2013 on March 11, 2014"
More From BioPortfolio on "BRIEF-OncoGenex says late-stage study of cancer drug to continue as planned after interim efficacy analysis"
More From BioPortfolio on "OncoGenex to Report Financial Results for Third Quarter 2013 and Address Key Questions from Investors on November 7, 2013"
...Johanna Bendell MD, Director of the GI Cancer Research Program, Sarah Cannon Research Institute (SCRI), and a primary investigator on the trial. "We are very excited to open enrollment in the Rainier trial, to explore the role of Hsp27 in pancreatic cancer and to evaluate for the potential ability of apatorsen to improve clinical outcomes for patients when added to combination chemotherapy."

More Content

All (47) | News (42) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
OncoGenex Pharmaceutical Makes a Move: Down 1.6% [Published Individual.com - Apr 16 2014]
OncoGenex Pharmaceutical Shares Down 15.3% Sinc... [Published Comtex SmarTrend - Apr 11 2014]
OncoGenex Pharmaceutical Shares Down 15.3% Sinc... [Published Individual.com - Apr 11 2014]
OncoGenex Pharmaceuticals Rating Increased to O... [Published American Banking News - Apr 09 2014]
Eli Lilly & Company (NYSE:LLY) – NY Family Wins... [Published Jutia Group - Apr 08 2014]
Shares of OncoGenex Pharmaceutical Are Down on ... [Published Individual.com - Apr 07 2014]
OncoGenex Pharmaceutical Shares Sinking Lower, ... [Published Comtex SmarTrend - Apr 04 2014]
Short Interest in OncoGenex Pharmaceuticals Ris... [Published Zolmax News - Apr 03 2014]
ONCOGENEX PHARMACEUTICALS : Reports Financial R... [Published 4 Traders - Mar 23 2014]
OncoGenex Pharmaceutical Shares Up 65.9% Since ... [Published Individual.com - Mar 21 2014]
OncoGenex Pharmaceuticals CMO Sells $15,313 in ... [Published American Banking News - Mar 19 2014]
Insider Selling: OncoGenex Pharmaceuticals CEO ... [Published American Banking News - Mar 19 2014]
Narrower-than-Expected Loss at OncoGenex - Anal... [Published Nasdaq - Mar 12 2014]
Narrower-than-Expected Loss at OncoGenex [Published Zacks.com - Mar 12 2014]
Shares of OncoGenex Pharmaceutical Under Pressu... [Published Comtex SmarTrend - Mar 12 2014]
OncoGenex Pharmaceuticals Inc. Reports Financia... [Published BioSpace - Mar 12 2014]
OncoGenex Pharmaceuticals Reports Financial Res... [Published HispanicBusiness.com - Mar 12 2014]
OncoGenex Pharma fourth quarter loss widens [Published MyIris - Mar 12 2014]
All That Jazz [Published MoneyShow.com - Mar 12 2014]
Frontrunning: March 12 [Published Zero Hedge - Mar 12 2014]
OncoGenex Pharmaceuticals' CEO Discusses Q4 201... [Published Seeking Alpha - Mar 12 2014]
OncoGenex Pharmaceuticals (OGXI) Announces Quar... [Published American Banking News - Mar 11 2014]
OncoGenex Pharmaceuticals Inc. Discusses Q4 201... [Published BioPortfolio - Mar 11 2014]
(CNW) OncoGenex Pharmaceuticals, Inc. Reports -2- [Published Scottrade - Mar 11 2014]
OncoGenex Pharmaceuticals, Inc. Reports Financi... [Published Noodls - Mar 11 2014]
ONCOGENEX PHARMACEUTICALS, INC. : Results of Op... [Published 4 Traders - Mar 11 2014]
OncoGenex Pharmaceuticals, Inc. Reports Financi... [Published SYS-CON Media - Mar 11 2014]
OncoGenex Pharmaceuticals, Inc. Reports Financi... [Published TickerTech.com - Mar 11 2014]
OncoGenex Pharmaceuticals, Inc. Reports Financi... [Published Financial Services - Mar 11 2014]
Big Biotech News Today? [Published MoneyShow.com - Mar 11 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Frontrunning: March 12 [Published Zero Hedge - Mar 12 2014]
China worries chill markets, copper slumps ( Reuters ) Peak dot com dot two idiocy: Candy Crush Saga maker King seeks $7.56 bln valuation from IPO ( BBG ) Obama Meeting With Yatsenyuk Raises Stakes in Ukraine ( BBG ) Federal prosecutors open criminal ...
OncoGenex to Report Financial Results for Fourt... [Published PR Newswire: Health - Feb 25 2014]
BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 25, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's fourth quarter and year-ended 2013 financial results will be released on Tuesday, March 11, ...
OncoGenex Announces Target Number of Events Rea... [Published PR Newswire: Health - Feb 11 2014]
BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 11, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the pre-specified number of events required for final analysis of the Phase 3 SYNERGY trial has been rea ...
OncoGenex to Present at Leerink Global Healthca... [Published PR Newswire: General Business - Feb 06 2014]
BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 6, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, President and Chief Executive Officer, will provide a corporate presentation at the Leerink ...
1

Press Releases

sort by: Date | Relevance
OncoGenex Pharmaceuticals, Inc. Reports Financi... [Published Financial Services - Mar 11 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.